-
2 New Ebola Vaccines Pass Important Early Test, Researchers Say
Two new Ebola vaccines have passed an important test, protecting monkeys against the strain of the virus responsible for the current deadly outbreak, researchers reported on Wednesday. Only one dose was needed, and there were no apparent side effects.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Oral Antibiotics Are Found to Save More Infant Lives
While vaccines, mosquito nets and other health measures have saved millions of children younger than 5 in the last decade, death rates from pneumonia, sepsis and meningitis among babies in the first weeks of life have remained stubbornly high.
- Categories
- Health Care
- Tags
- vaccines
-
Budget Cuts and Vaccine Fears Threaten Health Progress
Cuts to global health research budgets and people’s wariness of vaccines could hamper efforts to improve health around the world, two separate reports have warned in the run-up to World Health Day, which is marked today.
- Categories
- Education, Health Care
-
New Japanese Encephalitis Vaccine ‘A Historic Moment for Global Health’
As I prepare for retirement this month and reflect on my four years as the director of the neglected infectious diseases team here at the Bill & Melinda Gates Foundation, one of the things I am most proud of is to have been part of a global team that has been working to get a new Japanese encephalitis vaccine to the millions of people who need it.
- Categories
- Health Care
- Region
- Asia Pacific
- Tags
- vaccines
-
Crucial Vaccines Out of Reach for Many in Rural India
The Union health ministry's ambitious Mission Indradhanush to immunise children against various diseases faces a major challenge as the Hib vaccine to safeguard the little ones from deadly infections like meningitis, pneumonia and severe throat conditions remains out of the reach in vast areas of the country.
- Categories
- Health Care
- Region
- South Asia
-
GlaxoSmithKline and Merck Ebola Vaccines Succeed in Phase II Liberian Trials
Two Ebola vaccines, one developed by the NIH and GlaxoSmithKline ($GSK) and the other by Merck ($MRK) and NewLink ($NLNK), have sailed through Liberian trials and, based on the results, may now advance to Phase III trials.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Viewpoint: Where Do Vaccine Fears Come From?
In his 2013 New Yorker article “Slow Ideas,” the Harvard surgeon Atul Gawande offered a compelling way to understand why some good ideas spread slowly (if at all) while others spread like wildfire.
- Categories
- Health Care
- Tags
- vaccines
-
Microneedle Patches Could Be the Future of Vaccinations
Georgia Tech professor Mark Praunitz has spent two decades developing microneedle patches.
- Categories
- Health Care
- Tags
- vaccines
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.